Management of Patients With Aortic Valve Stenosis

2018/04/01 by Amrit Kanwar, Jeremy J. Thaden, Vuyisile T. Nkomo · 27 citations
Medicine · #Cardiac Valve Diseases and Treatments #Infective Endocarditis Diagnosis and Management #Aortic Disease and Treatment Approaches

paper · doi:10.1016/j.mayocp.2018.01.020

Cited by

• The Impact of Aortic Valve Stenosis on Pulse Wave Morphology: An in silico study with 16,038 virtual subjects
• Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia
• Patient-specific simulation of transcatheter aortic valve replacement: impact of deployment options on paravalvular leakage. [europepmc]
• Health-related quality of life following transcatheter aortic valve implantation using transaortic, transfemoral approaches and surgical aortic valve replacement-a single-center study. [europepmc]
• The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019. [europepmc]
• HDL-C Role in Acquired Aortic Valve Stenosis Patients and Its Relationship with Oxidative Stress. [europepmc]
• Toronto aortic stenosis quality of life questionnaire (TASQ): validation in TAVI patients. [europepmc]
• Current issues in transcatheter aortic valve replacement. [europepmc]
• Serum Biomarkers of Cardiovascular Remodelling Reflect Extra-Valvular Cardiac Damage in Patients with Severe Aortic Stenosis. [europepmc]
• Label-free metabolic biomarkers for assessing valve interstitial cell calcific progression. [europepmc]
• Differences in the presentation and management of patients with severe aortic stenosis in different European centres. [europepmc]
• Label-free optical biomarkers detect early calcific aortic valve disease in a wild-type mouse model. [europepmc]
• Personalized intervention cardiology with transcatheter aortic valve replacement made possible with a non-invasive monitoring and diagnostic framework. [europepmc]
• The Emerging Role of Nutraceuticals in Cardiovascular Calcification: Evidence from Preclinical and Clinical Studies. [europepmc]
• Aortic stenosis and Heyde's syndrome: A comprehensive review. [europepmc]
• A computational framework for post-TAVR cardiac conduction abnormality (CCA) risk assessment in patient-specific anatomy. [europepmc]
• Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases. [europepmc]
• Predictors of Mortality Following Aortic Valve Replacement in Aortic Stenosis Patients. [europepmc]
• Lithotripsy of Calcified Aortic Valve Leaflets by a Novel Ultrasound Transcatheter-Based Device. [europepmc]
• Prognostic Outcome of New-Onset Left Bundle Branch Block After Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis: A Systematic Review and Meta-Analysis. [europepmc]
• Outcome of transcatheter aortic valve replacement in patients over 85 years of age versus patients aged 85 and younger. [europepmc]
• Aortic Valve Stenosis: Diagnostic Approaches and Recommendations of the 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease -A Review of the Literature. [europepmc]
• Conscious sedation/monitored anesthesia care versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis. [europepmc]
• Aortic Valve Calcium Score by Computed Tomography as an Adjunct to Echocardiographic Assessment-A Review of Clinical Utility and Applications. [europepmc]
• Predictors, clinical impact, and management strategies for conduction abnormalities after transcatheter aortic valve replacement: an updated review. [europepmc]
• A biomarker framework for cardiac aging: the Aging Biomarker Consortium consensus statement. [europepmc]
• Association between cholesterol, high-density lipoprotein, and glucose index and risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis: the ARISTOTLE cohort study. [europepmc]